相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。UK guidelines on the management of variceal haemorrhage in cirrhotic patients
Dhiraj Tripathi et al.
GUT (2015)
To block, or not to block in advanced cirrhosis and ascites: that is the question
Aleksander Krag et al.
GUT (2015)
Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation
Joanna A. Leithead et al.
GUT (2015)
Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis
Mattias Mandorfer et al.
GASTROENTEROLOGY (2014)
When Should the β-Blocker Window in Cirrhosis Close?
Phillip S. Ge et al.
GASTROENTEROLOGY (2014)
Beta-Blockers in Cirrhosis Patients With Refractory Ascites
Anne Robins et al.
HEPATOLOGY (2014)
Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis
Christos Triantos et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Meta-analysis: banding ligation and medical interventions for the prevention of rebleeding from oesophageal varices
M. Thiele et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity
Florence Wong et al.
GUT (2012)
The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease
Aleksander Krag et al.
GUT (2012)
Is This Really the End of Beta-Blockers in Patients with Cirrhosis and Refractory Ascites?
Thierry Thevenot et al.
HEPATOLOGY (2011)
Effects of Beta-Blockers on Survival for Patients With Cirrhosis and Refractory Ascites
Gin-Ho Lo
HEPATOLOGY (2011)
Beta-Blockers in Patients with Cirrhosis and Refractory Ascites
Agustin Albillos et al.
HEPATOLOGY (2011)
Is Hydrophobia Necessary for the Hepatologist Prescribing Nonselective Beta-Blockers in Cirrhosis?
Marco Senzolo et al.
HEPATOLOGY (2011)
Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
William H. Shrank et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: A cross-over study
Thomas Serste et al.
JOURNAL OF HEPATOLOGY (2011)
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
A. Krag et al.
GUT (2010)
Beta-Blockers in Cirrhosis: Friend and Foe?
Florence Wong et al.
HEPATOLOGY (2010)
Deleterious Effects of Beta-Blockers on Survival in Patients With Cirrhosis and Refractory Ascites
Thomas Serste et al.
HEPATOLOGY (2010)
The management of portal hypertension: Rational basis, available treatments and future options
Jaime Bosch et al.
JOURNAL OF HEPATOLOGY (2008)
Prevention and management of Gastroesophageal varices and variceal Hemorrhage in cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2007)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
分享论文
